Join
Live feed
·
INSIDERFilingvia Quantisnow
Pressure BioSciences, Inc. logo

Pollack Kevin acquired $466 worth of shares (2,914 units at $0.16), increasing direct ownership by 9% to 36,787 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
PBIO· Pressure BioSciences, Inc.
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PBIO (Pressure BioSciences, Inc.) and more on Quantisnow.